Twist Bioscience

Valuation Analysis

About the Company

Twist Bioscience en bref

Twist Bioscience (TWST) is currently trading at 76,41 € with a market capitalization of 4,8 Md €. The 52-week range spans from 20,33 € to 77,20 €; the current price is 1% below the yearly high. Year-over-year revenue growth stands at +19.3%.

💰 Dividende

Twist Bioscience currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

10 analystes évaluent Twist Bioscience (TWST) au consensus : Achat Fort. L'objectif de cours moyen est de 62,05 €, soit un potentiel de -18.8% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 31,42 € à 78,54 €.

Twist Bioscience : la thèse d'investissement en détail

Twist Bioscience (TWST) operates in the Healthcare — specifically Diagnostics & Research — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 19.3% pace year-over-year, suggesting the business model continues to find new customers and pricing power.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. With a beta near 2.21, the share price moves sharply more than the broader market — drawdowns in market corrections can be unusually severe and require strong nerves. Short interest sits at 30.69% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

À surveiller

• The share is trading at 98.6% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to above-average price swings, elevated short interest (30.69%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Twist Bioscience?

Compare top-rated brokers — low fees, trusted providers, fully regulated.